You might have heard the news already. The FDA approved Biogen's drug Aduhelm (aducanumab). Everyone seems to be celebrating. See @jimcaster 's post :
healthunlocked.com/cure-par...
Not so fast, says this opinion piece from a Bloomberg writer:
bloomberg.com/opinion/artic...
RKM
Written by
To view profiles and participate in discussions please join or log in .
Reply Like (5)Save post Report
good article. Lays it all out.
Reply (2)Report
Why I am not joyous about this announcement:
- at $56,000 per year / person, it will likely take money from other parts of health care;
- it signals an acceptance of post-hoc analysis: if a trial gives the wrong answer, collect more data, and try again
Reply (4)Report
" if a trial gives the wrong answer, collect more data, and try again."
don't tell the believers and those who own Biogen stock about "post-hoc analysis" problems...(i.e. after the fact manipulation of the data).
Reply (1)Report
You may also like... da-approves-alzheimers-drug-aducanumab/
The FDA is directing the manufacturer, the biotech giant...
mmation-to-slow-parkinsons-disease
https://healthunlocked.com/cure-parkinsons/posts/148549565/acai-
LRRK2-associated #Parkinsons
https://clinicaltrials.gov/ct2/show/NCT05418673...
https://www.fusfoundation.org/news/fda-approves-focused-ultrasound-treatment-for-parkinsons-disease
michaeljfox.org/news/new-drug-fda-approved-parkinsons-time
View more posts